All In MedTech

Device Trial Radar · NCT04775316

Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing

C2654 - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing

Last checked: Nov 19, 2026Latest source record: Dec 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

47

Actual

Start

Sep 1, 2021

Primary completion

Nov 28, 2022

Study completion Nov 30, 2022

Sponsor

Lead sponsor
BSN Medical GmbHNot on our public-company list
Sponsor type
Industry
First posted
Mar 1, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Although, a huge number of acute wounds is treated successfully every year, Health Care Professionals (HCPs) are facing more and more problems when treating skin damages or surgical incisions: The number of patients with fragile and/or sensitive skin is highly increasing. Such patients are having a skin integrity issue, meaning the skin is vulnerable to injury, often damaged, or unable to heal. The investigational medical devices (IMDs) of the planned clinical evaluation, Leukomed® T skin sensitive and Leukomed® T plus skin sensitive have been developed for treatment of acute wounds on patients with fragile or sensitive skin to provide a reliable but skin-friendly fixation and wound care option. The primary purpose of this clinical study is the evaluation of clinical performance to stay in place up to seven days and the safety of both dressings. Further, data on wearing comfort, product handling, pain during removal and quality of life are considered as secondary outcomes. The products will be used as part of routine wound care within the scope of their intended purpose without any additional invasive or burdensome examination.

Conditions

  • Wounds and Injuries
  • Skin Diseases

Interventions

  • Leukomed T / Tplus skin sensitive treatmentDevice

    Application of sterile wound dressing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adhered dressing area after wearTime frame: 7 days after dressing application

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Practice Degenhardt

    Bremen, Germany

  • Klinikum Dortmund

    Dortmund, Germany

  • orthoGroup

    Hamburg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.